42. Drugs Used to Treat Disorders of the Urinary System



Drugs Used to Treat Disorders of the Urinary System


Objectives



Key Terms


pyelonephritis (image) (p. 666)


cystitis (image) (p. 666)


prostatitis (image) (p. 666)


urethritis (image) (p. 666)


acidification (image) (p. 669)


frequency (image) (p. 673)


urgency (image) (p. 673)


incontinence (image) (p. 673)


urge incontinence (image) (p. 673)


nocturia (image) (p. 673)


overactive bladder (OAB) syndrome (image image) (p. 673)


urinary antispasmodic agents (image image) (p. 674)


Urinary Tract Infections


image http://evolve.elsevier.com/Clayton


Urinary tract infections (UTIs) are among the most common infectious diseases in humans, accounting for more than 11 million health care providers’ office visits yearly. UTIs are second only to upper respiratory tract infections as a cause of morbidity from infection. UTIs encompass several different types of infection of local tissue: pyelonephritis (the kidney), cystitis (the bladder), prostatitis (the prostate gland), and urethritis (the urethra).


The incidence of UTIs in women is approximately 10 times higher than in men. A woman’s urethra is shorter than a man’s is, so bacteria have a shorter distance to travel to the bladder. Proximity of the urethral meatus to the vagina and rectum can also make it easier for bacteria to cause an infection. The incidence increases in women with age, so that by 60 years of age, up to 20% of women will have suffered from at least one UTI in their lives.


Gram-negative aerobic bacilli from the gastrointestinal tract cause most UTIs. Escherichia coli accounts for about 80% of noninstitutionally acquired uncomplicated UTIs. Other common infecting organisms are Staphylococcus saprophyticus, Klebsiella pneumoniae, Enterobacter species, Proteus mirabilis, and Pseudomonas aeruginosa. Nosocomial UTIs and those associated with urinary tract pathologic abnormalities are considered to be complicated UTIs. The pathogens tend to be the same types of bacteria, but they are frequently more resistant to the antibiotics commonly used. This requires the use of more potent antibiotics for longer courses of therapy, placing the patient at a greater risk for complications secondary to drug therapy.


The use of an indwelling urinary catheter should be avoided if possible. When used, adherence to strict aseptic technique and attachment to a closed drainage system is necessary to reduce the rate of infection.


imageNursing Implications for Urinary System Disease


The information the nurse gains through assessment of the patient’s clinical signs and symptoms is important to the health care provider when analyzing data for diagnosis and for evaluation of the patient’s response to prescribed treatment.


Assessment

History of Urinary Tract Symptoms


History of Current Symptoms


• Has the individual had any chills, fever, general malaise, or a change in mental status? New confusion in an older patient may be the only sign of a UTI. Ask questions relating to personal hygiene practices and sexual intercourse to evaluate for the possibility of bacterial contamination as an underlying cause of cystitis. Has the person been on prolonged bed rest for any reason?


• Pattern of urination: Ask the individual to describe the symptoms that affect his or her ability to void. What is the current urination pattern, and have there been recent changes? Such details as frequency, dysuria, incontinence, changes in the stream, hesitancy in starting to void, hematuria, nocturia (does he or she awaken at night with the desire to urinate and, if so, how many times does this occur during an average night?), and urgency are all of significance. Ask if he or she is able to sit through a 2-hour meeting or ride in a car for 2 hours without urinating. State the onset, course of progression of the symptoms, and any self-treatment that has been attempted and response achieved. Is there blood or pus in the urine? Is it difficult to postpone urination when the urge to urinate is felt? Is there incontinence (leaking) of urine? If so, when does this happen and what causes it? Does the incontinence occur when coughing, walking, running, lifting a heavy object, or if one is unable to reach a toilet immediately?


• Pattern of pain: Record the details of any pain the patient describes—frequency, intensity, duration, and location. Use a pain rating scale (0-10, 0 for no pain; 10 for severe pain). Pain associated with renal pathology usually occurs at the groin, back, flank, and suprapubic area and on urination (dysuria). Does the pain radiate? If so, obtain details.


• Intake and output: Ask specifically about the individual’s usual daily fluid intake. How frequently does the patient usually void? What is the amount of each voiding?



image Life Span Considerations


Urinary Tract Infections


In children and men, UTIs may have a more serious cause than a case of cystitis. Therefore, all UTIs must be thoroughly investigated to identify the underlying cause.


Medication History.

Ask for a list of all prescribed over-the-counter medicines and herbal products being taken. Many pharmacologic agents (e.g., anticholinergic agents, cholinergic agents, antihistamines, antihypertensives, chemotherapeutic agents, and immunosuppressants) can induce urinary retention or an altered urinary elimination pattern or urologic symptoms. Has the person recently been on medications to prevent or treat a UTI?


Nutritional History


Laboratory and Diagnostic Studies.

Review diagnostic and laboratory reports (e.g., urinalysis, renal function tests, voiding evaluatory procedures, cystoscopy, and complete blood count [CBC] with differential, urine culture, and sensitivity results).


Urinalysis is a physical, chemical, and microscopic examination of the urine, and is the most routine test that the nurse encounters. The color, appearance (e.g., clear, foamy, turbid), and odor of the urine are noted, and the pH, protein, glucose, and ketones are determined with reagent dipsticks. Specific gravity is measured with a refractometer, and a microscopic examination of the urinary sediment is performed to detect the presence of red and white blood cells, bacteria, casts, and crystals. An understanding of the significant data that this basic test can reveal is imperative to monitoring the patient. Refer to Table 42-1 for a description of the data. See a general medical-surgical text for details of collecting urine samples correctly.



Table 42-1


Urinalysis




















































PROPERTY NORMAL DATA ABNORMAL DATA
Color, appearance Straw, clear yellow, or amber Dark smoky color, reddish, or brown may indicate blood; white or cloudy may indicate UTI or chyluria; dark yellow to amber may indicate dehydration; green, deep yellow, or brown may indicate liver or biliary disease; some drugs or food also alter urine color: red or red brown, foods (e.g., beets, rhubarb); orange, phenazopyridine (Pyridium); dark yellow or brown, nitrofurantoin; blue, methylene blue; bright yellow, vitamin B complex; reddish orange, rifampin
Odor Ammonia-like on standing Foul smell may indicate infection; dehydrated patient’s urine is concentrated, ammonia smell resulting from urea breakdown by bacteria is apparent; sweet or fruity odor associated with starvation or diabetic acidosis (ketoacidosis)
Protein 0 to trace Foamy or frothy-appearing urine may indicate protein; proteinuria associated with kidney disease, toxemia of pregnancy, also found in leukemia, lupus erythematosus, cardiac disease
Glucose 0 to trace Presence usually associated with diabetes mellitus or low renal threshold with glucose “spillage” also seen at times of severe stress (e.g., major infection) or after high-carbohydrate intake
Ketones 0 Associated with dehydration, starvation, ketoacidosis, diet high in protein and low in carbohydrates
pH 4.5-8.0 pH <4.5 indicates metabolic acidosis, respiratory acidosis, diet high in meat protein and/or cranberries; medications can be prescribed to produce alkaline or acidic urine; pH >8.0 associated with bacteriuria (UTI from Klebsiella or Proteus), diet high in fruits and/or vegetables
Red blood cell count 0-3/high-power field (HPF) Indicative of bleeding at some location in the urinary tract; infection, obstruction, calculi, renal failure, tumors, anticoagulants, excess aspirin, menstrual contamination
White blood cell count 0-5/HPF Increase indicates infection somewhere in urinary tract; may also be associated with lupus nephritis, strenuous exercise
Casts 0 May indicate dehydration, possible infection within renal tubules, other types of renal disease
Bacteria 0 May indicate UTI or contaminated specimen collection
Specific gravity (sp gr) 1.003-1.029 Used as indicator of hydration (in absence of renal pathology); sp gr >1.018 is early sign of dehydration; sp gr <1.010 is “dilute urine,” may indicate fluid accumulation; fixed sp gr ≅1.010 may indicate renal disease; sp gr <1.005 may indicate diabetes insipidus, excess fluid intake, overhydration; sp gr >1.026 may indicate decreased fluid intake, vomiting, diarrhea, diabetes mellitus

UTI, urinary tract infection.


Implementation


• Individualize the care plan to address the type of urinary tract disorder (e.g., retention, incontinence, or cystitis).


• Administer medications prescribed and list on the medication administration record (MAR), or in the electronic medical record.


• Monitor laboratory studies (e.g., urinalysis, CBC with differential, and creatinine clearance).


• Mark dietary orders on Kardex or enter data into the computer; indicate the amount of fluid to be taken every shift to maintain an adequate intake.


• Mark the Kardex or enter data into the computer for daily weights and accurate intake and output as appropriate to diagnosis, indicate whether bladder training, Kegel exercises, or other measures should be taught and encouraged.


• Indicate the level of activity or exercise permitted.


• Review treatment protocol and algorithms developed by the U.S. Department of Health and Human Services for the management of incontinence in adults.


• Perform focused assessment of symptoms (e.g., retention, urinary frequency, and pain).


• Monitor the pain level and provide appropriate supportive and pharmacologic interventions.


• Administer prescribed medications; monitor response and adverse effects.


• Maintain adequate fluid intake and an accurate intake and output record. Instruct the patient to avoid foods known to be bladder irritants, such as spicy foods, citrus juices, alcohol, and caffeine.


• For inability to void, institute techniques to stimulate voiding (e.g., proper positioning to void, running water in sink, and pouring warm water over perineum).


• For incontinence, establish a regular toileting schedule, initiate bladder-training measures as appropriate and as ordered. Start measures to prevent perineal irritation. Apply external urinary diversion devices as ordered, such as an external condom (Texas catheter). Use incontinent pads as needed. Keep the urinal or bedpan readily available.


• Facilitate modifications of the environment that promote regular, easy access to toilet facilities, and promote the patient’s safety with features such as better lighting, ambulatory assistance equipment, clothing alterations, timed voiding, and different toileting equipment.


• Implement measures to maintain the individual’s dignity and privacy and to prevent embarrassment when incontinence is present.


• Maintain the activity and exercise level prescribed.


image Patient Education and Health Promotion

For Incontinence


For Urinary Tract Infections


• Teach women the following measures to avoid future UTIs: avoid nylon underwear (use cotton) and tight, constrictive clothing in the perineal area; avoid frequent use of bubble bath; wash the perineal area immediately before and after sexual intercourse; and urinate immediately after intercourse.


• Explain the correct procedure for obtaining a clean-catch urine sample and the importance of having follow-up urine cultures collected as requested by the health care provider.


• Teach comfort measures, such as the use of a sitz bath.


• Stress the importance of adequate fluid intake and its effect of diluting the urine, decreasing bladder irritability, and helping remove organisms present in the bladder. Define “adequate intake of fluid” to the individual in terms of the number and size of glasses of liquid to be consumed during the day.


• Explain the signs of improvement or worsening of the urinary condition appropriate to the individual’s diagnosis. Emphasize symptoms that should be reported to the health care provider.


For Urinary Retention.

Teach self-examination to assess for bladder distention, Credé’s maneuver (manual compression of the bladder through pressure on the lower abdomen) to aid in emptying the bladder and, as appropriate, self-catheterization.


Medications


• For urinary retention, explain adverse effects to anticipate with the prescribed medications.


• For the urinary analgesic phenazopyridine hydrochloride, explain that the urine will be reddish orange. If discoloration of the skin or sclera occurs, contact the health care provider.


• For UTIs, instruct patients to take the medicines exactly as prescribed for the entire course of medication. Discontinuing the antimicrobial agent when the symptoms improve may result in another infection after approximately 2 weeks that will be resistant to antimicrobial treatment. See individual drug monographs for specific instructions relating to acidification of the urine and instructions on taking medications with food or milk to avoid gastric irritation.


• See individual drug monographs regarding treatment of acute attacks and how long before response can be anticipated. Stress the need for follow-up laboratory evaluation to evaluate response to therapy.


Fostering Health Maintenance


Written Record.

Enlist the patient’s aid in developing and maintaining a written record of monitoring parameters for urinary antimicrobial agents. (See Patient Self-Assessment Form for Urinary Antibiotics on the image Evolve Web site at http://evolve.elsevier.com/Clayton.) Complete the Premedication Data column for use as a baseline to track response to therapy. Ensure that the patient understands how to use the form and instruct the patient to take the completed form to follow-up visits. During follow-up visits, focus on issues that will foster adherence with the therapeutic interventions prescribed.


Drug Therapy for Urinary Tract Infections


Urinary Antimicrobial Agents


Actions


Urinary antimicrobial agents are substances that are secreted and concentrated in the urine in sufficient amounts to have an antiseptic effect on the urine and urinary tract.


Uses


Selection of the product to be used is based on identification of the pathogens by Gram staining or by urine culture in severe, recurrent, or chronic infections.


Fosfomycin, norfloxacin, methenamine mandelate, and nitrofurantoin are used only for UTIs. Examples of other antibiotics that are also used to treat urinary infections are ampicillin, sulfisoxazole, co-trimoxazole, ciprofloxacin, levofloxacin, tetracycline, doxycycline, and gentamicin. These agents are effective in a variety of tissue infections against many different microorganisms. Because of their use in multiple organ systems, they are discussed in detail (with nursing process) in Chapter 46.


Fluid intake should be encouraged so that there will be at least 2000 mL of urinary output daily. Duration of treatment depends on whether the infection is uncomplicated or complicated; acute, chronic, or recurrent; the pathogen being treated; the antimicrobial agent being used for treatment; and whether a follow-up culture can be collected to assess the success of the therapy.


Drug Class: Fosfomycin Antibiotics



fosfomycin (image)


Monurol (image)

< div class='tao-gold-member'>

Stay updated, free articles. Join our Telegram channel

Jul 11, 2016 | Posted by in NURSING | Comments Off on 42. Drugs Used to Treat Disorders of the Urinary System

Full access? Get Clinical Tree

Get Clinical Tree app for offline access